Ep68: The Future of Mental Health Care

DTx Podcast with Eugene Borukhovich

English - June 13, 2023 07:08 - 35 minutes - ★★★★★ - 9 ratings
Health & Fitness Technology Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Ep67: Transforming Health Care with Virtual Reality

Next Episode: Ep69: From Summit to Success: Exploring the Exciting Developments in the Digital Therapeutics Industry

In this episode, we hear from Jenna Carl PhD, Chief Medical Officer at Big Health. Big Health believes in mental health care for all and that their digital therapeutics are safe and effective non-drug options for mental health.
In this episode, we cover:

Consumer Experience with Sleepio vs Daylight: Gain insights into the end consumer experience and how these solutions are designed to improve sleep and mental well-being.

Go-to-Market Strategy: Explore Big Health's go-to-market strategy, and activating employers to reach upstream employees and achieve high engagement rates.

Deep Dive into the Relationship with CVS: Gain a deeper understanding of Big Health's relationship with CVS, specifically regarding medication targeting.

Abandoning Direct-to-Consumer (DTC): Uncover the reasons behind Big Health's decision to shift away from a direct-to-consumer approach and explore the implications of this strategic shift.

Clinical Evidence and Decision-making Processes: Learn about Big Health's extensive clinical study basis and the rationale behind this approach.

Future Product Pipeline: Gain insights into Big Health's future plans for additional products and the exciting developments in their pipeline.

Big Health and Pear's Differing Go-To-Market Strategies: Explore the differing go-to-market routes between Big Health and Pear Therapeutics

Stand-alone DTx vs. Disease Management 2.0: Understand the merits and challenges of stand-alone digital therapeutics versus disease management 2.0

Guest Links and Resources:

Connect with Jenna Carl on LinkedIn

Visit BigHealth.com

Episode PDF

Host Links:

Connect with Eugene Borukhovich: Twitter | LinkedIn

Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn

Connect with YourCoach.health: Website | Twitter

Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App

HealthXL: Website | Twitter | Join an Event

Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Partners and Sponsors: Akili | Bayer G4A | Lindus Health

Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode, we cover:

Consumer Experience with Sleepio vs Daylight: Gain insights into the end consumer experience and how these solutions are designed to improve sleep and mental well-being.
Go-to-Market Strategy: Explore Big Health's go-to-market strategy, and activating employers to reach upstream employees and achieve high engagement rates.
Deep Dive into the Relationship with CVS: Gain a deeper understanding of Big Health's relationship with CVS, specifically regarding medication targeting.
Abandoning Direct-to-Consumer (DTC): Uncover the reasons behind Big Health's decision to shift away from a direct-to-consumer approach and explore the implications of this strategic shift.
Clinical Evidence and Decision-making Processes: Learn about Big Health's extensive clinical study basis and the rationale behind this approach.
Future Product Pipeline: Gain insights into Big Health's future plans for additional products and the exciting developments in their pipeline.
Big Health and Pear's Differing Go-To-Market Strategies: Explore the differing go-to-market routes between Big Health and Pear Therapeutics
Stand-alone DTx vs. Disease Management 2.0: Understand the merits and challenges of stand-alone digital therapeutics versus disease management 2.0